Effectiveness of trivalent influenza vaccine among children in two consecutive seasons in a community in Japan

Tsubasa Suzuki, Yasuhiko Ono, Hidenori Maeda, Yoshiki Tsujimoto, Yugo Shobugawa, Clyde Dapat, Mohd Rohaizat Hassan, Chihiro Yokota, Hiroki Kondo, Isolde C. Dapat, Kousuke Saito, Reiko Saito

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Influenza vaccination is considered the single most important medical intervention for the prevention of influenza. The dose of trivalent influenza vaccine in children was increased almost double since 2011/12 season in Japan. We estimated the influenza vaccine effectiveness for children 1-11 years of age using rapid test kits in Isahaya City, involving 28,884 children-years, over two consecutive influenza seasons (2011/12 and 2012/13). Children were divided into two groups, vaccinated and unvaccinated, according to their vaccination record, which was obtained from an influenza registration program organized by the Isahaya Medical Association for all pediatric facilities in the city. There were 14,562 and 14,282 children aged from 1-11 years in the city in 2011 and 2012 respectively. In the 2011/12 season, the overall vaccine effectiveness in children from 1-11 years of age, against influenza A and B were 23% [95% confidence interval (CI): 14%-31%] and 20% [95% CI: 8%-31%], respectively. In the 2012/13 season, vaccine effectiveness against influenza A and B was 13% (95% CI: 4%-20%) and 9% (95% CI: -4%-21%), respectively. The vaccine effectiveness was estimated using the rapid diagnosis test kits. Age-stratified estimation showed that vaccine effectiveness was superior in younger children over both seasons and for both virus types. In conclusion, the trivalent influenza vaccine has a significant protective effect for children 1-11 years of age against influenza A and B infection in the 2011/12 season and against influenza A infection in the 2012/13 season in a community in Japan.

Original languageEnglish
Pages (from-to)97-104
Number of pages8
JournalTohoku Journal of Experimental Medicine
Volume232
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Influenza Vaccines
Human Influenza
Japan
Vaccines
Confidence Intervals
Pediatrics
Viruses
Vaccination
Infection

Keywords

  • Children
  • Community
  • Influenza virus
  • Trivalent influenza vaccine
  • Vaccine effectiveness

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Effectiveness of trivalent influenza vaccine among children in two consecutive seasons in a community in Japan. / Suzuki, Tsubasa; Ono, Yasuhiko; Maeda, Hidenori; Tsujimoto, Yoshiki; Shobugawa, Yugo; Dapat, Clyde; Hassan, Mohd Rohaizat; Yokota, Chihiro; Kondo, Hiroki; Dapat, Isolde C.; Saito, Kousuke; Saito, Reiko.

In: Tohoku Journal of Experimental Medicine, Vol. 232, No. 2, 2014, p. 97-104.

Research output: Contribution to journalArticle

Suzuki, T, Ono, Y, Maeda, H, Tsujimoto, Y, Shobugawa, Y, Dapat, C, Hassan, MR, Yokota, C, Kondo, H, Dapat, IC, Saito, K & Saito, R 2014, 'Effectiveness of trivalent influenza vaccine among children in two consecutive seasons in a community in Japan', Tohoku Journal of Experimental Medicine, vol. 232, no. 2, pp. 97-104. https://doi.org/10.1620/tjem.232.97
Suzuki, Tsubasa ; Ono, Yasuhiko ; Maeda, Hidenori ; Tsujimoto, Yoshiki ; Shobugawa, Yugo ; Dapat, Clyde ; Hassan, Mohd Rohaizat ; Yokota, Chihiro ; Kondo, Hiroki ; Dapat, Isolde C. ; Saito, Kousuke ; Saito, Reiko. / Effectiveness of trivalent influenza vaccine among children in two consecutive seasons in a community in Japan. In: Tohoku Journal of Experimental Medicine. 2014 ; Vol. 232, No. 2. pp. 97-104.
@article{13e2bffc930c4908be42566b16090506,
title = "Effectiveness of trivalent influenza vaccine among children in two consecutive seasons in a community in Japan",
abstract = "Influenza vaccination is considered the single most important medical intervention for the prevention of influenza. The dose of trivalent influenza vaccine in children was increased almost double since 2011/12 season in Japan. We estimated the influenza vaccine effectiveness for children 1-11 years of age using rapid test kits in Isahaya City, involving 28,884 children-years, over two consecutive influenza seasons (2011/12 and 2012/13). Children were divided into two groups, vaccinated and unvaccinated, according to their vaccination record, which was obtained from an influenza registration program organized by the Isahaya Medical Association for all pediatric facilities in the city. There were 14,562 and 14,282 children aged from 1-11 years in the city in 2011 and 2012 respectively. In the 2011/12 season, the overall vaccine effectiveness in children from 1-11 years of age, against influenza A and B were 23{\%} [95{\%} confidence interval (CI): 14{\%}-31{\%}] and 20{\%} [95{\%} CI: 8{\%}-31{\%}], respectively. In the 2012/13 season, vaccine effectiveness against influenza A and B was 13{\%} (95{\%} CI: 4{\%}-20{\%}) and 9{\%} (95{\%} CI: -4{\%}-21{\%}), respectively. The vaccine effectiveness was estimated using the rapid diagnosis test kits. Age-stratified estimation showed that vaccine effectiveness was superior in younger children over both seasons and for both virus types. In conclusion, the trivalent influenza vaccine has a significant protective effect for children 1-11 years of age against influenza A and B infection in the 2011/12 season and against influenza A infection in the 2012/13 season in a community in Japan.",
keywords = "Children, Community, Influenza virus, Trivalent influenza vaccine, Vaccine effectiveness",
author = "Tsubasa Suzuki and Yasuhiko Ono and Hidenori Maeda and Yoshiki Tsujimoto and Yugo Shobugawa and Clyde Dapat and Hassan, {Mohd Rohaizat} and Chihiro Yokota and Hiroki Kondo and Dapat, {Isolde C.} and Kousuke Saito and Reiko Saito",
year = "2014",
doi = "10.1620/tjem.232.97",
language = "English",
volume = "232",
pages = "97--104",
journal = "Tohoku Journal of Experimental Medicine",
issn = "0040-8727",
publisher = "Tohoku University Medical Press",
number = "2",

}

TY - JOUR

T1 - Effectiveness of trivalent influenza vaccine among children in two consecutive seasons in a community in Japan

AU - Suzuki, Tsubasa

AU - Ono, Yasuhiko

AU - Maeda, Hidenori

AU - Tsujimoto, Yoshiki

AU - Shobugawa, Yugo

AU - Dapat, Clyde

AU - Hassan, Mohd Rohaizat

AU - Yokota, Chihiro

AU - Kondo, Hiroki

AU - Dapat, Isolde C.

AU - Saito, Kousuke

AU - Saito, Reiko

PY - 2014

Y1 - 2014

N2 - Influenza vaccination is considered the single most important medical intervention for the prevention of influenza. The dose of trivalent influenza vaccine in children was increased almost double since 2011/12 season in Japan. We estimated the influenza vaccine effectiveness for children 1-11 years of age using rapid test kits in Isahaya City, involving 28,884 children-years, over two consecutive influenza seasons (2011/12 and 2012/13). Children were divided into two groups, vaccinated and unvaccinated, according to their vaccination record, which was obtained from an influenza registration program organized by the Isahaya Medical Association for all pediatric facilities in the city. There were 14,562 and 14,282 children aged from 1-11 years in the city in 2011 and 2012 respectively. In the 2011/12 season, the overall vaccine effectiveness in children from 1-11 years of age, against influenza A and B were 23% [95% confidence interval (CI): 14%-31%] and 20% [95% CI: 8%-31%], respectively. In the 2012/13 season, vaccine effectiveness against influenza A and B was 13% (95% CI: 4%-20%) and 9% (95% CI: -4%-21%), respectively. The vaccine effectiveness was estimated using the rapid diagnosis test kits. Age-stratified estimation showed that vaccine effectiveness was superior in younger children over both seasons and for both virus types. In conclusion, the trivalent influenza vaccine has a significant protective effect for children 1-11 years of age against influenza A and B infection in the 2011/12 season and against influenza A infection in the 2012/13 season in a community in Japan.

AB - Influenza vaccination is considered the single most important medical intervention for the prevention of influenza. The dose of trivalent influenza vaccine in children was increased almost double since 2011/12 season in Japan. We estimated the influenza vaccine effectiveness for children 1-11 years of age using rapid test kits in Isahaya City, involving 28,884 children-years, over two consecutive influenza seasons (2011/12 and 2012/13). Children were divided into two groups, vaccinated and unvaccinated, according to their vaccination record, which was obtained from an influenza registration program organized by the Isahaya Medical Association for all pediatric facilities in the city. There were 14,562 and 14,282 children aged from 1-11 years in the city in 2011 and 2012 respectively. In the 2011/12 season, the overall vaccine effectiveness in children from 1-11 years of age, against influenza A and B were 23% [95% confidence interval (CI): 14%-31%] and 20% [95% CI: 8%-31%], respectively. In the 2012/13 season, vaccine effectiveness against influenza A and B was 13% (95% CI: 4%-20%) and 9% (95% CI: -4%-21%), respectively. The vaccine effectiveness was estimated using the rapid diagnosis test kits. Age-stratified estimation showed that vaccine effectiveness was superior in younger children over both seasons and for both virus types. In conclusion, the trivalent influenza vaccine has a significant protective effect for children 1-11 years of age against influenza A and B infection in the 2011/12 season and against influenza A infection in the 2012/13 season in a community in Japan.

KW - Children

KW - Community

KW - Influenza virus

KW - Trivalent influenza vaccine

KW - Vaccine effectiveness

UR - http://www.scopus.com/inward/record.url?scp=84896975254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896975254&partnerID=8YFLogxK

U2 - 10.1620/tjem.232.97

DO - 10.1620/tjem.232.97

M3 - Article

C2 - 24531035

AN - SCOPUS:84896975254

VL - 232

SP - 97

EP - 104

JO - Tohoku Journal of Experimental Medicine

JF - Tohoku Journal of Experimental Medicine

SN - 0040-8727

IS - 2

ER -